GB virus infection: a silent anti-HIV panacea within?

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 102, Issue 12, 2008, Pages 1176-1180

  Shankar, Esaki Muthu ^a   Solomon, Sunil Suhas ^a   Vignesh, Ramachandran ^a   Murugavel, Kailapuri G ^a   Sundaram, Muthu ^a   Solomon, Suniti ^a   Balakrishnan, Pachamuthu ^a   Kumarasamy, Nagalingeswaran ^a  

^a YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

Author keywords

Disease progression; GB virus; Hepatitis; HIV; Intravenous drug users; Transmission

Indexed keywords

ANTIRETROVIRUS AGENT; BETA CHEMOKINE; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; VIRUS PROTEIN;

ANTIVIRAL RESISTANCE; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; FLAVIVIRUS; HEPATITIS G; HEPATITIS G VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; INDIA; INHIBITION KINETICS; INTRAVENOUS DRUG ABUSE; MEDICAL RESEARCH; PERIPHERAL BLOOD MONONUCLEAR CELL; RECEPTOR BINDING; REVIEW; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSMISSION;

CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DISEASE PROGRESSION; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HIV INFECTIONS; HUMANS; VIRAL INTERFERENCE;

FLAVIVIRIDAE; GB VIRUS C;

EID: 54949158288     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2008.04.034     Document Type: Review

References (41)

1. Alter H.J., Nakatsuji Y., Melpolder J., Wages J., Wesley R., Shih J.W., and Kim J.P. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N. Engl. J. Med. 336 (1997) 747-754
2. Bhatnagar, N., Moenkemeyer, M., Hong, H., Schimidt, R., Heiken, H., 2007. Plasmacytoid dendritic cells expressing CD40+ and CD83+ are increased in HIV-1 patients with GBV-C co-infection, in: 14th Conference on Retroviruses and Opportunistic Infections (CROI); 25-28 February 2007; Los Angeles, CA [Abstract 928].
3. Björkman P., Nauclér A., Winqvist N., Mushahwar I., and Widell A. A case-control study of transmission routes for GB virus C/hepatitis G virus in Swedish blood donors lacking markers for hepatitis C virus infection. Vox Sang. 81 (2001) 148-153
4. Björkman, P., Flambolc, L., Naucler, A., Wallmark, VE., Widell, A., 2003. GB virus C viremia during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality, in: 10th Conference on Retroviruses and Opportunistic Infections (CROI); 10-14 February 2003; Boston, MA [Abstract 157].
5. + T-lymphocyte cell line. J. Gen. Virol. 88 (2007) 3341-3346
6. Dawson G.J., Schlauder G.G., Pilot-Matias T.J., Thiele D., Leary T.P., Murphy P., Rosenblatt J.E., Simons J.N., Martinson F.E.A., Gutierrez R.A., Lentino J.R., Pachucki C., Muerhoff A.S., Widell A., Tegtmeier G., Desai S., and Mushahwar I.K. Prevalence studies of GB virus-C infection using reverse transcriptase-polymerase chain reaction. J. Med. Virol. 50 (1996) 97-103
7. Heringlake S., Osterkamp S., Trautwein C., Tillmann H.L., Böker K., Muerhoff S., Mushahwar I.K., Hunsmann G., and Manns M.P. Association between fulminant hepatic failure and a strain of GB virus C. Lancet 348 (1996) 1626-1629
8. Kennedy N., Tong C.Y.W., Beeching N.J., Lamden K., Williams H., Mutton K.J., and Hart C.A. Hepatitis G virus infection in drug users in Liverpool. J. Infect. 37 (1998) 140-147
9. Leary T.P., Muerhoff A.S., Simons J.N., Pilot-Matias T.J., Erker J.C., Chalmers M.L., Schlauder G.G., Dawson G.J., Desai S.M., and Mushahwar I.K. Sequence and genomic organization of GBV-C: a novel member of the Flaviviridae associated with human non-A-E hepatitis. J. Med. Virol. 48 (1996) 60-67
10. Lefrère J.J., Roudot-Thoraval F., Morand-Joubert L., Brossard Y., Parnet-Mathieu F., Mariotti M., Agis F., Rouet G., Lerable J., Lefèvre G., Girot R., and Loiseau P. Prevalence of GB virus type C/hepatitis G virus RNA and of anti-E2 in individuals at high or low risk for blood-borne or sexually transmitted viruses: evidence of sexual and parenteral transmission. Transfusion 39 (1999) 83-94
11. Linnen J., Wages J., Zhang-Keck Z.-Y., Fry K.E., Krawczynski K.Z., Alter H., Koonin E., Gallagher M., Alter M., Hadziyannis S., Karayiannis P., Fung K., Nakatsuji Y., Shih J.W.K., Piatak M., Hoover C., Fernandez J., Chen S., Zou J.-C., Morris T., Hyams K.C., Ismay S., Lifson J.D., Hess G., Foung S.K.H., Thomas H., Bradley D., Margolis H., and Kim J.P. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 271 (1996) 505-508
12. Lui K.J., Darrow W.W., and Rutherford G.W. A model-based estimate of the mean incubation period for AIDS in homosexual men. Science 240 (1988) 1333-1335
13. Moaven L.D., Hyland C.A., Young I.F., Bowden D.S., McCaw R., Mison L., and Locarnini S.A. Prevalence of hepatitis G virus in Queensland blood donors. Med. J. Aust. 165 (1996) 369-371
14. Nattermann J., Nischalke H.D., Kupfer B., Rockstroh J., Hess L., Sauerbruch T., and Spengler U. Regulation of CC chemokine receptor 5 in hepatitis G virus infection. AIDS 17 (2003) 1457-1462
15. Nunnari G., Nigro L., Palermo F., Attanasio M., Berger A., Doerr H.W., Pomerantz R.J., and Cacopardo B. Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile. Ann. Intern. Med. 139 (2003) 26-30
16. Patterson S., Robinson S.P., English N.R., and Knight S.C. Subpopulations of peripheral blood dendritic cells show differential susceptibility to infection with a lymphotropic strain of HIV-1. Immunol. Lett. 66 (1999) 111-116
17. Patterson S., Rae A., Hockey N., Gilmour J., and Gotch F. Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus. J. Virol. 75 (2001) 6710-6713
18. Puig-Basagoiti F., Cabana M., Guilera M., Gimenez-Barcons M., Sirera G., Tural C., Sánchez-Tapias J.M., Rodés J., Saiz J.C., and Martínez M.A. Prevalence and route of transmission of infection with a novel DNA virus (TTV), hepatitis C virus, and hepatitis G virus in patients infected with HIV. J. Acquir. Immune Defic. Syndr. 23 (2000) 89-94
19. Radkowski M., Kubicka J., Kisiel E., Cianciara J., Nowicki M., Rakela J., and Laskus T. Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects. Blood 95 (2000) 3986-3989
20. Reed K.E., and Rice C.M. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr. Top. Microbiol. Immunol. 242 (2000) 55-84
21. Rey D., Fraize S., Vidinic J., Meyer P., Fritsch S., Labouret N., Schmitt C., Lang J.M., and Stoll-Keller F. High prevalence of GB virus C/hepatitis G virus RNA in patients infected with human immunodeficiency virus. J. Med. Virol. 57 (1999) 75-79
22. Rowland-Jones S. Long-term non-progression in HIV infection: clinico-pathological issues. J. Infect. 38 (1999) 67-70
23. Ryt-Hansen R., Katzenstein T.L., Gerstoft J., and Eugen-Olsen J. No influence of GB virus C on disease progression in a Danish cohort of HIV-infected men. AIDS Res. Hum. Retroviruses 22 (2006) 496-498
24. Sabin C.A., Devereux H., Kinson Z., Griffioen A., Brown D., Dusheiko G., and Lee C.A. Effect of coinfection with hepatitis G virus on HIV disease progression in hemophilic men. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19 (1998) 546-548
25. Sawayama Y., Hayashi J., Etoh Y., Urabe H., Minami K., and Kashiwagi S. Heterosexual transmission of the GB virus C/hepatitis G virus infection to non-intravenous drug-using female prostitutes in Fukuoka, Japan. Dig. Dis. Sci. 44 (1999) 1937-1943
26. Schlauder G.G., Dawson G.J., Simons J.N., Pilot-Matias T.J., Gutierrez R.A., Heynen C.A., Knigge M.F., Kurpiewski G.S., Buijk S.L., Leary T.P., Muerhoff A.S., Desai S.M., and Mushahwar I.K. Molecular and serologic analysis in the transmission of the GB hepatitis agents. J. Med. Virol. 46 (1995) 81-90
27. Schreier E., Höhne M., Kunkel U., Berg T., and Hopf U. Hepatitis GBV-C sequences in patients infected with HCV contaminated anti-D immunoglobulin and among i.v. drug users in Germany. J. Hepatol. 5 (1996) 385-389
28. Seipp S., Scheidel M., Hofmann W.J., Tox U., Theilmann L., Goeser T., and Kallinowski B. Hepatotropism of GB virus C (GBV-C): GBV-C replication in human hepatocytes and cells of human hepatoma cell lines. J. Hepatol. 30 (1999) 570-579
29. Simons J.N., Pilot-Matias T.J., Leary T.P., Dawson G.J., Desai G.J., Desai S.M., Schlauder G.G., Muerhoff A.S., Erker J.C., Buijk S.L., and Chalmers M.J. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc. Natl. Acad. Sci. USA 92 (1995) 3401-3405
30. Soumelis V., Scott I., Gheyas F., Bouhour D., Cozon G., Cotte L., Huang L., Levy J., and Liu Y.J. Depletion of circulating natural type-1 interferon-producing cells in HIV-infected AIDS patients. Blood 98 (2001) 906-912
31. Stapleton J.T. GB virus type C/hepatitis G virus. Semin. Liver Dis. 23 (2003) 137-148
32. Tillmann H.L., Heiken H., Knapile-Botor A., Heringlake S., Ockenga J., Wilber J., Goergen B., Detmer J., McMorrow M., Stoll M., Schmidt R.E., and Manns M.P. Infection with GB virus C and reduced mortality among HIV-infected patients. N. Engl. J. Med. 345 (2001) 715-724
33. Tillmann H.L., Stoll M., Manns M.P., Schimidt R.E., and Heiken H. Chemokine receptor polymorphisms and GB virus C status in HIV-positive patients. AIDS 16 (2002) 808-809
34. Toyoda H., Fukuda Y., Hayakawa T., Takamatsu J., and Saito H. Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 17 (1998) 209-213
35. Xiang J., Wunschmann S., Schmidt W.N., Shao J., and Stapleton J.T. Full-length GB virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. J. Virol. 74 (2000) 9125-9133
36. Xiang J., Wunschmann S., Diekema D.J., Klinzman D., Patrick K.D., George S.L., and Stapleton J.T. Effect of coinfection with GB virus C (hepatitis G virus) on survival among patients with HIV infection. N. Engl. J. Med. 345 (2001) 707-714
37. Xiang J., George S.L., Wunschmann S., Chang Q., Klinzman D., and Stapleton J.T. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1 alpha, MIP-1 beta, and SDF-1. Lancet 363 (2004) 2040-2046
38. Xiang, J., McLinden, J., Chang, Q., Klinzman, D., Kaufman, T., Montefiori, D.C., Engel, A., Hess, G., Zdunek, D., Stapleton, J.T., 2006a. Monoclonal antibodies directed against the GB virus C major envelope glycoprotein neutralize HIV infectivity differentially in PBMC than in TZB-bl cells, in: 13th Conference on Retroviruses and Opportunistic Infections (CROI); 5-8 February 2006; Denver, CO [Abstract].
39. + Jurkat T cells. Proc. Natl. Acad. Sci. USA 103 (2006) 15570-15575
40. Xiang, J., McLinden, J., Chang, Q., Kaufman, T., Stapleton, J.T., 2006c. Deletion mapping of the GB virus C nonstructural protein 5A identifies a 69 amino acid region required for inhibition of HIV replication in Jurkat cells, in: 13th Conference on Retroviruses and Opportunistic Infections (CROI); 5-8 February 2006; Denver, CO [Abstract 211].
41. Yeo A.E.T., Matsumoto A., Hisada M., Shih J.W., Alter H.J., and Goedert J.J. Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study. Ann. Intern. Med. 132 (2000) 959-963